Treatment of Erythema Multiforme Without Mucosal Involvement, No Evidence of Infection, and No Recent Causative Medication
Clinical Scenario
This protocol addresses patients with erythema multiforme who present without mucosal involvement, with no evidence of active infection, and with no recently identified causative medication.
Treatment Approach
The focus is on symptomatic relief. Topical agents are part of the management approach, with additional measures available depending on symptom burden.
The complete regimen — including specific agents, indications for each, and selection guidance — is available in the full protocol below.
Treatment Goal
Regression of erythema multiforme skin lesions. In acute presentations, lesions typically resolve over several weeks; supportive treatment is directed at improving symptoms in the interim.
References
DOI: 10.3390/medicina57090921
- Once the etiology has been addressed, acute EM can be managed with topical steroids or antihistamines, if needed to improve symptoms.
- Treatment for acute or isolated cases of EM typically do not need intervention, but in cases where patients are experiencing uncomfortable symptoms, topical steroids, antiseptics, and oral antihistamines are recommended.
- Use topical corticosteroids or antihistamines for symptomatic disease.
- In acute disease, treatment is rarely needed as the lesions will typically regress over the course of several weeks, and supportive treatment is focused on improving symptoms.
View source ↗